lobbying_activities: 2102545

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2102545	74fad7c9-b64b-40ff-bf1d-01f2005585b0	Q1	RED+BLUE STRATEGIES	400693064	PEW CHARITABLE TRUSTS	2018	first_quarter	MMM	H.R. 1625/PL 115-141 - Consolidated Appropriations Act of 2018 - Issues related to policies regarding antibiotic resistance, compounding, policies surrounding access to prescription medications and policies to combat the opioid crisis in the United States. H.R. 1301/PL 115-124 - Continuing Resolution of 2018 - Issues related access and affordability of prescription medications in the United States, treatment of biosimilars and generics in public and private insurance and policies to combat the opioid crisis in the United States. CMS regulations related to Medicare Part D and promulgation of laws related to curbing substance use disorder among Medicare beneficiaries. Issues related to health information technology, unique device identifiers on Medicare claims forms, and other critical policies to promote device safety.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2018-04-06T15:25:52.453000-04:00